Changes in transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 in patients with lower urinary tract dysfunction

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose: We investigated the association between transient receptor potential vanilloid (TRPV) expression in human urothelium tissue and lower urinary tract dysfunction (LUTD). Materials and Methods: We prospectively enrolled men who planned to undergo surgical treatment for benign prostatic obstruction to analyze TRPV1 and TRPV4 expression in the urothelium using enzyme-linked immunosorbent assay and immunofluorescence staining. Patients were divided into two groups based on urodynamics: the detrusor underactivity (DU) group and the nonDU group. Levels of TRPV1 and TRPV4 were compared between the two groups. We also divided patients into two groups according to degree of subjective urinary urgency symptoms using a 5-point urinary sensation scale and compared the differences in TRPV1 and TRPV4 levels between the two groups. The correlations between urodynamic parameters with TRPV1 or TRPV 4 in all patients were also analyzed. Results: The levels of TRPV1 and TRPV 4 were not significantly different between the DU group (n=10) and the non-DU group (n=11). When we divided the patients according to degree of subjective urgency, the level of TRPV1 was not significantly different between the urgency group (n=10) and the non-urgency group (n =11), but the level of TRPV4 was significantly increased in the urgency group (p=0.029). There was no significant correlation between the level of TRPV1 or TRPV4 and urodynamic parameters in any patients. Conclusions: TRPV4 could be a useful diagnostic biomarker for patients with LUTD.

References Powered by Scopus

Transient receptor potential cation channels in disease

1220Citations
N/AReaders
Get full text

Urothelial signaling

374Citations
N/AReaders
Get full text

N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino} -3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2- carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I [S]

349Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Mechanotransduction in the urothelium: ATP signalling and mechanoreceptors

6Citations
N/AReaders
Get full text

Novel pharmacotherapeutic avenues for bladder storage dysfunction in men

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Cho, K. J., Koh, J. S., Choi, J. B., Park, S. H., Lee, W. S., & Kim, J. C. (2022). Changes in transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 in patients with lower urinary tract dysfunction. Investigative and Clinical Urology, 63(3), 309–315. https://doi.org/10.4111/icu.20210418

Readers' Seniority

Tooltip

Researcher 2

100%

Readers' Discipline

Tooltip

Neuroscience 1

50%

Psychology 1

50%

Save time finding and organizing research with Mendeley

Sign up for free